Anesthesia CO2 Absorbent Market Size, Share, Growth, Trends and Forecast Report
by Susan Hill Business ConsultantGlobal anesthesia CO2 absorbent market is expected to reach
USD 79.1 million by 2022, according to a new report by Grand View Research,
Inc. Rising geriatric population, increasing usage of regional anesthesia, and
augmenting volume of surgical procedures across the globe are vital impact
rendering drivers for the market.
Anesthesia CO2 absorbent forms a
niche segment within the anesthesia disposables, the demand for which is
expected to rise with increasing number of surgeries. According to the
statistics provided by the WHO in collaboration with the Department of Health
Policy and Management of Harvard, the global surgical volume is high and
accounts for about 234 million surgeries per year.
Furthermore, with this increase, a proportional rise
in complications and deaths after surgery are being witnessed. According to the
statistics provided by the U.S. Agency for Healthcare Research and Quality, one
in 150 patients dies due to improper administration of anesthesia.
The Harvard School of Public Health’s study links
economic conditions of a country with volume of surgeries and states that
prevalence of major surgeries is 37 times higher in countries with healthcare
expenditure above USD 1,000 per person.
Further
key findings from the study suggest:
- Amsorb is expected to witness the fastest growth over the forecast
period owing to increasing demand for absorbents free from presence of KOH
and clarity in exhaustion indication. Amsorb is anticipated to grow at a
CAGR of over 10.0% over the next seven years and contribute about 14.0%
revenue to the industry.
- Latin America and Asia Pacific are predicted to be the fastest growing
regions for the anesthesia CO2 absorbent market. Together,
they are expected to hold over 25.0% of the market share by 2022.
Strategic reforms in healthcare policies and increasing healthcare
spending patterns are expected to be the market drivers within the region.
- Key players of the industry include GE Healthcare, Smiths Medical,
CareFusion (Becton Dickinson and Co.), Armstrong Medical, and Drager
Medical GmbH. Other players include King Pharmaceuticals, Allied
Healthcare Products, Molecular Products, Micropore, and Medisize. GE
Healthcare’s vital sign division responsible for manufacturing of
anesthesia CO2 absorbent was acquired by CareFusion in
2013, thereby making it a leader for single patient use consumables for
anesthesiology.
- Also, cases of patent infringement are being reported by players
such as Drager. In October 2015, the company filed a patent infringement
lawsuit against Allied Healthcare alleging infringement carbolyme single
use carbon dioxide absorption cartridges. This action is anticipated to
help the company maintain its market share and control competition.
Access
full research report on global anesthesia CO2 absorbent market:
www.grandviewresearch.com/industry-analysis/anesthesia-co2-absorbent-market
Sponsor Ads
Created on Jan 27th 2020 08:01. Viewed 339 times.